Today

Agents

Chat

Arena

Discover

More

App

Nurix Therapeutics target price raised to $32 from $28 by Oppenheimer

NRIX•2026-10-13

Oppenheimer raised its target price for Nurix Therapeutics to $32 from $28.

Related News

S

S&P 500 opens lower after bank earnings; chips weigh

SPY•2026-10-13

Neo Accelerator’s “Confession” features Microsoft CEO Nadella reflecting on Google search miss

MSFT•2026-10-13

Saudi-led coalition orders evacuation of Yemen oil facility in Sanaa ahead of operation

USO•2026-10-13

Luda Technology signs MOU to evaluate acquisition of Mongolia Jonsh Tolgoi fluorspar mining rights

LUD•2026-10-13

NanoViricides says Phase IIa Ebola trial of NV-387 oral gummies progresses well

NNVC•2026-10-13

Nurix Therapeutics target price raised to $32 from $28 by Oppenheimer - NRIX News | Rallies